Statement of Retraction: Can Metformin reduce the incidence of Gestational Diabetes Mellitus in pregnant women with polycystic ovary syndrome? Prospective Cohort Study
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Gynecological Endocrinology |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09513590.2024.2401196 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
by: Paola Quaresima, et al.
Published: (2025-01-01) -
Role of Metformin in Reducing the Incidence of Gestational Diabetes Mellitus in Obese Women
by: Shazia Rasul, et al.
Published: (2024-12-01) -
Statement of Retraction: Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial
Published: (2024-12-01) -
Statement of Retraction: Long-term effects of combined simvastatin and metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome
Published: (2024-12-01) -
Risk for Gestational Diabetes Mellitus and Adverse Birth Outcomes in Chinese Women with Polycystic Ovary Syndrome
by: Qing Xiao, et al.
Published: (2016-01-01)